Coronary heart disease secondary prevention diabetes mellitus management

Coronary heart disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Coronary heart disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening and Risk Stratification
Natural History, Complications and Prognosis
Diagnosis
Pretest Probability
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Coronary heart disease secondary prevention diabetes mellitus management On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Coronary heart disease secondary prevention diabetes mellitus management All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Coronary heart disease secondary prevention diabetes mellitus management
CDC on Coronary heart disease secondary prevention diabetes mellitus management
Coronary heart disease secondary prevention diabetes mellitus management in the news
Blogs on Coronary heart disease secondary prevention diabetes mellitus management
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Coronary heart disease secondary prevention diabetes mellitus management

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

ACC / AHA 2011 Guidelines - Coronary Heart Disease - Secondary Prevention with Diabetes Mellitus Management (DO NOT EDIT) =

Class I

"1. Care for diabetes should be coordinated with the patient's primary care physician and/or endocrinologist. (Level C)"

"2. Lifestyle modifications including daily physical activity, weight management, blood pressure control, and lipid management are recommended for all patients with diabetes.([[ACC AHA guidelines classification scheme#Level of Evidence|Level B)"

Class IIa

"1. Metformin is an effective first-line pharmacotherapy and can be useful if not contraindicated.(Level A)"

"2. It is reasonable to individualize the intensity of blood sugar–lowering interventions based on the individual patient's risk of hypoglycemia during treatment. (Level C)"

Class IIb

"1. Initiation of pharmacotherapy interventions to achieve target HbA1c may be reasonable. (Level A)"

"2. A target HbA1c of ≤7% may be considered. (Level C)"

"3. Less stringent HbA1c goals may be considered for patients with a history of severe hypoglycemia, limited life expectancy, advanced microvascular or macrovascular complications, or extensive comorbidities, or those in whom the goal is difficult to attain despite intensive therapeutic interventions. (Level C)" References Template:WikiDoc Sources